Patrick T. Ryan Appointed to American Renal Associates Board of Directors
May 05 2016 - 04:25PM
Business Wire
American Renal Associates Holdings, Inc. (NYSE: ARA), a leading
provider of dialysis services, announced today that Patrick (Pat)
T. Ryan was appointed to the company’s board of directors. Ryan
currently serves as Chief Executive Officer of Press Ganey
Holdings, Inc. (NYSE: PGND), a position he has held since 2012. Mr.
Ryan will serve on ARA’s board of directors and as a member of the
board’s audit committee.
“We are very pleased to welcome Pat Ryan to the ARA board,” said
Joseph (Joe) Carlucci, Chairman, CEO and Co-Founder of American
Renal Associates. “We believe Pat’s considerable experience and
broad perspectives across the health care sector will complement
our existing board of directors and senior management team. Pat
understands that high-performing health care organizations need to
be aligned with physicians, staff and patients alike to provide
high quality care.”
“I am honored to be appointed to ARA’s board of directors,” said
Patrick T. Ryan. “I have known and admired the ARA team for many
years and believe the organization’s operating philosophy and
physician partnership model have propelled ARA’s outstanding
reputation. I look forward to serving on ARA’s board and being
associated with this unique organization.”
Pat Ryan brings more than 35 years of health care experience to
the ARA board. Prior to joining Press Ganey, Ryan has a
distinguished career serving in leadership roles across a wide
variety of health care organizations, including CEO of The
Broadlane Group, CEO of PolyMedica Corporation, Chairman and CEO of
Physicians Dialysis, Inc., CEO of Principalcare Inc., President and
CEO of ImageAmerica Inc. and Co-Founder and President of R.B.
Diagnostics. He began his career working for American Hospital
Supply Corporation. Ryan presently serves on the board of directors
of Affiliated Managers Group, Inc. (NYSE: AMG) and ChoiceOne Urgent
Care, LLC.
About American Renal Associates:
As of December 31, 2015, American Renal Associates Holdings,
Inc. (NYSE: ARA) operated 192 dialysis clinic locations in 24
states and the District of Columbia, treating over 13,000 patients
with end stage renal disease. ARA operates exclusively through a
physician joint venture model, in which it partners with 347 local
nephrologists to develop, own and operate dialysis clinics. For
more information about American Renal Associates, visit
www.americanrenal.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160505006692/en/
American Renal Associates Holdings, Inc.Darren Lehrich,
978-922-3080 x 134SVP of Strategy & Investor
Relationsdlehrich@americanrenal.com
American Renal Associates (NYSE:ARA)
Historical Stock Chart
From Feb 2024 to Mar 2024
American Renal Associates (NYSE:ARA)
Historical Stock Chart
From Mar 2023 to Mar 2024